A prospective, randomized trial of steroid withdrawal with mycophenolate (MMF) vs. sirolimus (SRL) in pancreas after kidney (PAK) transplants

被引：0

|

作者：

Kandaswamy, R

Khwaja, K

Gruessner, AC

Gruessner, RW

Humar, A

Glumac, E

Sutherland, DER

机构：

来源：

TRANSPLANTATION | 2003年 / 76卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

52

引用

收藏

页码：S35 / S36

页数：2

相关论文

共 50 条

[21] Results of a Prospective Randomized Trial of Sirolimus Conversion in Kidney Transplant Recipients on Early Corticosteroid Withdrawal
Heilman, Raymond. L.
Younan, Kerrie
Wadei, Hani M.
Mai, Martin L.
Reddy, Kunam S.
Chakkera, Harini A.
Gonwa, Thomas A.
TRANSPLANTATION, 2011, 92 (07) : 767 - 773
[22] A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year
Mendez, R
Gonwa, T
Yang, HC
Weinstein, S
Jensik, S
Steinberg, S
TRANSPLANTATION, 2005, 80 (03) : 303 - 309
[23] Efficacy and safety of mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy after calcineurin inhibitor (CNI) withdrawal in renal transplant recipients: Final results of the spare-the-nephron (STN) trial.
Pearson, T. C.
Mulgaonkar, S.
Patel, A.
Scandling, J.
Shidban, H.
Weir, M.
Patel, D.
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 213 - 213
[24] Final renal function outcomes from the spare-the-nephron (STN) trial: Mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy and CNI withdrawal in renal transplant recipients
Mulgaonkar, S.
Pearson, T. C.
Patel, A.
Scandling, J.
Shidban, H.
Weir, M.
Patel, D.
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 320 - 320
[25] Pilot study of thymoglobulin (THY), sirolimus (SRL) and mycophenolate mofetil (MMF): A calcineurin-inhibitors(CNI) free, steroid sparing and likely tolerogenic protocol for kidney allotransplantation (KTX)
Ambrosini, Andrea
Donati, Donato
Marconi, Alberto
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 265 - 266
[26] Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low-dose corticosteroids in primary kidney transplantation: 18-year results (vol 34, e14123, 2020)
Ciancio, G.
Gaynor, J. J.
Guerra, G.
CLINICAL TRANSPLANTATION, 2021, 35 (12)
[27] Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation
Dunn, B
Asolati, M
Holman, DM
Raofi, V
Jovanovic, B
Pollak, R
Benedetti, E
SURGERY, 1999, 125 (02) : 155 - 159
[28] Improved Growth in Pediatric Kidney Recipients after Early Steroid Withdrawal: Daclizumab, Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) Versus TAC, MMF and Steroids (TWIST Study).
Trompeter, S.
Grenda, R.
Watson, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 365 - 365
[29] Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation: A prospective and randomised study.
Cantarovich, D
Karam, G
Giral, M
Hourmant, M
Dantal, J
Blancho, G
Soulillou, JP
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 562 - 562
[30] REDUCED COMPLICATIONS AFTER EARLY STEROID WITHDRAWAL IN PAEDIATRIC KIDNEY RECIPIENTS: DACLIZUMAB (DAC), TACROLIMUS (TAC) AND MYCOPHENOLATE MOFETIL (MMF) VERSUS TAC, MMF AND STEROIDS (TWIST STUDY)
Watson, A. R.
Grenda, R.
Trompeter, R. S.
PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1799 - 1799

← 1 2 3 4 5 →